What are the opening hours?

Monday 9am - 5:30pm Tuesday 9am - 5:30pm Wednesday 9am - 5:30pm Thursday 9am - 5:30pm Friday 9am - 5:30pm

Cancer Screening Trust

Home
United Kingdom
London
Cancer Screening Trust

A non-profit organisation dedicated to providing the latest in cancer screening for early detection in over 70 types of cancer.

01/05/2024

Trucheck FemmeSafe is now available at The Cancer Screening Trust. It is a blood-based screening test based on the presence of Circulating Tumour Cells and validated to detect: breast, ovarian, uterine and cervical cancer.

Cancers of the breast, o***y, uterus and cervix account for approximately 3.6 million diagnosed cases and 1.3 million deaths in women worldwide, each year (Globocan, 2020). Early detection of these cancers results in more effective treatments and increased survival prospects.

Find out more and enquire today on our website: www.thecancerscreeningtrust.co.uk/screening-tests

19/04/2024

April is Bowel Cancer Awareness month in the UK. Bowel cancer is the fourth most common cancer in the UK and the second biggest cancer killer. Nearly 43,000 individuals are diagnosed with bowel cancer every year in the UK (Bowel Cancer UK, July 2023). The FIT test is used as a bowel cancer screening method and is now available at CST for all individuals over 18 years old.

Find out more on our website and enquire today: www.thecancerscreeningtrust.co.uk

01/03/2024

The Cancer Screening Trust are offering a Comprehensive Hereditary Cancer Panel that includes 31 genes associated with the most common hereditary cancers. It is used to identify individuals at a higher-than population risk for hereditary cancer from a simple saliva sample.

Find out more on our website: www.thecancerscreeningtrust.co.uk/screening-tests

09/02/2024

In recent light of World Cancer Day, The Cancer Screening Trust are here to support people and communities to raise awareness and take action against cancer. Detecting cancer as early as possible allows individuals to have the best chance for successful treatment. Screening can help prevent the development of cancers and detect it at an early stage. It is estimated that over 5000 lives are saved by the cancer screening programmes each year in the UK (www.news.cancerresearchuk.org/2024/02/02/world-cancer-day-2024). The Cancer Screening Trust aim to increase this, with the Trucheck Intelli blood test that is validated to detect over 70 different types of cancer at the earliest of stages. Find out more on our website: www.thecancerscreeningtrust.co.uk

29/01/2024

Datar Cancer Genetics, who developed Trucheck Intelli, have conducted research studies on a 'world-first' blood test which can diagnose glial tumours including: glioblastoma (GBM), the most commonly-diagnosed high-grade brain tumour in adults, astrocytomas and oligodendrogliomas. They found the test had 'high analytical sensitivity, specificity and precision'. Such a non-invasive and inexpensive method for early detection of brain tumours is critical for improvements in patient care.

Whilst there is still some way to go, it uses similar methods to that of Trublood by detecting intact circulating tumour cells from the blood, which can be analysed to the same cellular detail as an actual tissue sample.

CST are currently offering Trublood products as well as a number of others, find out more on our website: www.thecancerscreeningtrust.co.uk

05/01/2024

One person a minute in Britain will be diagnosed with cancer by 2040 according to a recent article from The Times (www.thetimes.co.uk/article/cancer-diagnosis-warning-2040-research-uk-sb8bdrg2z). Investment in research to prevent this is failing to keep up with the ever-increasing burden of cancer according to Michelle Mitchel, chief executive of Cancer Research UK. In the UK, there are an estimated 419,935 cases of cancer annually and if the present trend persists, this will rise to 505,565 by 2040 along with deaths from 176,376 to 208,022.

With a focus on healing yourself, middle-aged adults can help prevent thousands of cases by removing unhealthy habits from their lifestyle such as smoking, excessive drinking, and obesity.

However, there are reasons to be optimistic, one being the use of blood tests as an early diagnostic screening method. In the UK, a worse prognosis is generally thought to be caused by late diagnosis where cancers are typically harder to treat. Blood tests such as Trucheck Intelli can be used as a screening tool to detect cancers at the earliest stages using Circulating Tumour Cells with 88.2% sensitivity. Early detection means that treatment is more likely to be successful. Find out more on our website today: www.thecancerscreeningtrust.co.uk

02/01/2024

Happy New Year to everyone from CST! We have achieved lots during a busy year thanks to our hard working staff, clinical team and loyal clients. In 2023, we started providing genetic tests for cancer, successfully made it through to the next stage of the Somerset Business Awards, ran a marathon for cancer awareness and had a Telegraph article written for CST and the Trucheck Intelli blood test. We aim to continue to support the early detection of cancer and change lives in 2024.

13/12/2023

We are delighted to announce that The Cancer Screening Trust has successfully made it through to the next round of the Somerset Business Awards in the Start-Up of the Year category. We are glad that this recognition will help us with our mission to spread awareness about early cancer detection.

14/11/2023

CST would like to give Dan Hogarty a huge congratulations in completing his first marathon in Venice with flying colours and continuing to raise awareness for early cancer detection.

10/10/2023

October is breast cancer awareness month, raising awareness around screening, treatment and prevention of breast cancer.

Currently, breast cancer is the most common cancer found in women with 1 in 8 women diagnosed with breast cancer in their lifetime (NBCF).

Trucheck Intelli can detect 81% of all cancer cases, including breast cancer at even the most earliest stages which is key to successful outcomes. Reach out and make an enquiry today on our website: www.thecancerscreeningtrust.co.uk

04/10/2023

Dan Hogarty recently completed The Big Half marathon in London in preparation for his marathon in Venice coming up at the end of this month. The Cancer Screening Trust is proud to be sponsoring Dan on his first marathon, especially as he is raising money for his niece. Shortly after the birth of her incredible daughter Opal last year, Maddy, Dan's cousin, was diagnosed with a rare and aggressive form of brain cancer. She handled the ensuing surgery and treatment with astonishing grace and courage, accompanied every step of the way by her family and devoted husband, Ben. She spent her final weeks at her parents’ home, bathed in love and calm, and with the sounds of nature all around. Please read more and donate here https://gofund.me/b35dec7f

Address

Zeal House, 8 Deer Park Road, Merton
London
SW193UU

Opening Hours

Monday	9am - 5:30pm
Tuesday	9am - 5:30pm
Wednesday	9am - 5:30pm
Thursday	9am - 5:30pm
Friday	9am - 5:30pm

Website

https://www.thecancerscreeningtrust.co.uk/

Alerts

Be the first to know and let us send you an email when Cancer Screening Trust posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Cancer Screening Trust:

Shortcuts

Featured

Help Mind Body

Want your practice to be the top-listed Clinic in London?